Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
MC

MICHAEL CALVO

BRISTOL-MYERS SQUIBB COMPANY · WASHINGTON, DC
Registered · LDAActive
Request introduction →Claim this profile →

At a glance

Works on
Copyright/Patent/TrademarkHealth IssuesMedicare/MedicaidTaxation/Internal Revenue CodeTrade (domestic/foreign)
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
BRISTOL-MYERS SQUIBB COMPANY
WASHINGTON, DC · current

The past 12 months

Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATE

Specific issues

H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.7391, CHC Drug Pricing Protection Act H.R.5509, Safe Step Act Issues related to biosimilars reimbursement issues Clinical Trial Modernization Act
Health Issues · 2026 Q1
Intellectual Property Reform concerning bio-pharmaceutical industry
Copyright/Patent/Trademark · 2026 Q1
International Reference Pricing/Most Favored Nation, including all bio-pharmaceutical issues
Trade (domestic/foreign) · 2026 Q1
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act
Medicare/Medicaid · 2026 Q1
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation
Taxation/Internal Revenue Code · 2026 Q1

Clients

BRISTOL-MYERS SQUIBB COMPANY
2026 · 1 filing
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings1
2026 Q1
BRISTOL-MYERS SQUIBB COMPANY
Q1lda.gov →